Join BJS Academy
BJS Academy>Randomized clinical ...>Antibiotic prophylax...
Normal View Dyslexic View

Antibiotic prophylaxis in breast cancer surgery (PAUS trial): randomised clinical double-blind parallel-group multicentre superiority trial.

26 January 2023
Randomized clinical trials Breast
Stallard S, Savioli F, McConnachie A, Norrie J, Dudman K, Morrow ES et al.

Br J Surg 2022; 109: 1224–1231.

In this study that included 871 procedures, a single dose of Amoxicillin-clavulanic acid did not reduce the risk of wound infection up to 30 days: 16.2 per cent versus 19.2 per cent in controls, P=0.25.

Comment: not beneficial even in higher risk subgroups – obese or Staph aureus carriers.

BJS Foundation Limited
BJS Academy
0000-0000
BJS Foundation Limited
London, UK
rct149
Randomized clinical trials
Randomized clinical trials
Breast
Antibiotic prophylaxis in breast cancer surgery (PAUS trial): randomised clinical double-blind parallel-group multicentre superiority trial.
Stallard S, Savioli F, McConnachie A, Norrie J, Dudman K, Morrow ES et al.
26012023
Br J Surg 2022; 109: 1224–1231.
In this study that included 871 procedures, a single dose of Amoxicillin-clavulanic acid did not reduce the risk of wound infection up to 30 days: 16.2 per cent versus 19.2 per cent in controls, P=0.25.
Comment: not beneficial even in higher risk subgroups – obese or Staph aureus carriers.
Published on: 26 January 2023
Article ID: rct149

Related articles

Aspirin vs placebo as adjuvant therapy for breast cancer. The Alliance A011502 randomized trial.

Chen WY, Ballman KV, Partridge AH, Hahn OM, Briccetti FM et al.

16 August 2024

21-Gene assay to inform chemotherapy benefit in node-positive breast cancer.

Kalinsky K, Barlow WE, Gralow JR, Meric-Bernstam F, Albain KS, Hayes DF et al.
N Engl J Med 2021; 385: 2336-2347

1 January 2022

Event-free survival with pembrolizumab in early triple-negative breast cancer.

Schmid P, Cortes J, Dent R, Pusztai L, McArthur H, Kummel S et al, for the KEYNOTE-522 Investigators.
N Engl J Med 2022; 386: 556-567.

1 March 2022
Home
  • Normal view
  • Dyslexic view
Info
Copied!